Application of iPS technology for NKT cell-mediated tumor immunotherapy
Yamada, D.; Koseki, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 5): 257-260
2015
ISSN/ISBN: 0047-1852 PMID: 30457808 Document Number: 681431
Document emailed within 1 workday
Related Documents
Adler, A.; Keisari, Y.; Ofir, R. 1985: Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy Journal of the National Cancer Institute 74(2): 429-436Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Tanaka, T.; Saito, T. 1975: Immunotherapy of cancer: induction of tumor immunity with a mixture of tumor cell-BCG, and the effect of intratumor injection of BCG and of nonliving BCG preparation Gan 66(6): 631-640
Perek, Y.; Hurwitz, E.; Burowski, D.; Haimovich, J. 1983: Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM Journal of Immunology 131(3): 1600-1603
Nishimura, T.; Kuge, S.; Watanabe, K.; Lee, U.; Yahata, T.; Habu, S. 1994: An efficient methods for the induction of human antitumor effector CD4+ and CD8+ T cells: their application to tumor immunotherapy Human Cell 7(3): 131-137
Schirrmacher, V.; von Hoegen, P.; Heicappell, R. 1989: Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells Progress in Clinical and Biological Research 288: 391-399
Mizushima, Y.; Sendo, F.; Miyake, T.; Kobayashi, H. 1981: Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan Journal of the National Cancer Institute 66(4): 659-665
Deo, Y.M.; Sundarapandiyan, K.; Keler, T.; Wallace, P.K.; Graziano, R.F. 1998: Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood Journal of Immunology 160(4): 1677-1686
Yoshizawa, H.; Chang, A.E.; Shu, S.Y. 1992: Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells Cancer Research 52(5): 1129-1136
Norbury, K.C. 1977: In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations Cancer Research 37(5): 1408-1415
Bridges, S.H.; Longo, D.L. 1990: T cell tumor cure by T cell receptor-mediated activation requires the development of CD8-dependent host immunity Journal of Immunology 144(5): 2010-2017
Vlodavsky, I.; Fuks, Z.; Bar-Ner, M.; Ariav, Y.; Schirrmacher, V. 1983: Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis Cancer Research 43(6): 2704-2711
Hanna, M.G.; Peters, L.C.; Hoover, H.C. 1989: Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines Progress in Clinical and Biological Research 310: 51-65
Noto, T.; Tokuda, Y.; Tajima, T.; Mitomi, T.; Nakamura, Y.; Watanabe, K.; Yamamura, M.; Ichinohe, K. 1989: A new high-yield continuous cell culture system and its clinical application in adoptive immunotherapy with LAK cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-3): 1893-1898
Herman, C.J.; Pelgrim, O.; Kirkels, W.J.; Debruyne, F.M.; Vooijs, G.P. 1983: 'Viable' tumor cells in posttherapy biopsy specimens. a potential application of human tumor clonogenic cell culture Archives of Pathology and Laboratory Medicine 107(2): 81-83
Hahn, E.; Lehmann, F.G.; Ferlemann, J.; Ax, W.; Hamelmann, H.; Hort, W.; Havemann, K. 1977: Immunotherapy of a metastasized primary liver cell carcinoma with autologous tumor cells and BGC Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 1205-1208
Van de Loosdrecht, A.A.; Ossenkoppele, G.J.; Beelen, R.H.; Broekhoven, M.G.; Langenhuijsen, M.M. 1993: Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins Cancer Research 53(18): 4399-4407
You, J.; Yu, J-pu.; Ren, X-bao.; Wang, C-li.; Zhang, P.; Zhang, X-zeng. 2004: Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 26(6): 333-336
Yang, S.C.; Owen-Schaub, L.; Mendiguren-Rodriguez, A.; Grimm, E.A.; Hong, W.K.; Roth, J.A. 1990: Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha Journal of Thoracic and Cardiovascular Surgery 99(1): 8
Alfieri, A.A.; Hahn, E.W.; Kim, J.H. 1981: Role of cell-mediated immunity in tumor eradication by hyperthermia Cancer Research 41(4): 1301-1305